Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics. Motoyama M, Shigefuku R, Tanaka N, Nishizawa M, et al. Anticancer Res 2025;45:433-443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Motoyama M, Shigefuku R, Tanaka N, Nishizawa M, et al. Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics. Anticancer Res 2025;45:433-443.
PMID: 39890166